BAJAJ BROKING

Notification close image
No new Notification messages
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

539680

GANGAPHARM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Ganga Pharmaceuticals Limited Share Price Update

As of the latest trading session, Ganga Pharmaceuticals Limited share price is currently at ₹ 14.6, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 14.60 and ₹ 14.60. Over the past year, Ganga Pharmaceuticals Limited has achieved a return of -25.39 %. In the last month alone, the return has been [-] %. Read More...

Investment Returns

Over 1 Month 0.00% Over 3 Months 0.00% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Ganga Pharmaceuticals Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    7.10

  • P/E Ratio (TTM)

    91.25

  • Beta

    4.08

  • Book Value / share

    13.46

  • Return on equity

    1.13%

  • EPS (TTM)

    0.16

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Ganga Pharmaceuticals Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 2.64
Operating Expense 2.98
Net Profit 0.08
Net Profit Margin (%) 3.03
Earnings Per Share (EPS) 0.16
EBITDA 0.32
Effective Tax Rate (%) 22.22
Particulars MAR 2024 (Values in Cr)
Revenue 2.74
Operating Expense 2.91
Net Profit 0.05
Net Profit Margin (%) 1.82
Earnings Per Share (EPS) 0.11
EBITDA 0.29
Effective Tax Rate (%) 33.33
Particulars MAR 2023 (Values in Cr)
Revenue 2.59
Operating Expense 2.83
Net Profit 0.04
Net Profit Margin (%) 1.54
Earnings Per Share (EPS) 0.10
EBITDA 0.30
Effective Tax Rate (%) 20.00
Particulars MAR 2022 (Values in Cr)
Revenue 2.49
Operating Expense 2.69
Net Profit 0.04
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 0.09
EBITDA 0.29
Effective Tax Rate (%) 20.00
Particulars MAR 2021 (Values in Cr)
Revenue 2.37
Operating Expense 2.59
Net Profit 0.02
Net Profit Margin (%) 0.84
Earnings Per Share (EPS) 0.05
EBITDA 0.28
Effective Tax Rate (%) 50.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 13.46
ROE % 1.13
ROCE % 3.30
Total Debt to Total Equity 0.20
EBITDA Margin 12.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.30
ROE % 0.80
ROCE % 3.18
Total Debt to Total Equity 0.25
EBITDA Margin 10.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.42
ROE % 0.74
ROCE % 3.28
Total Debt to Total Equity 0.35
EBITDA Margin 11.58
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.32
ROE % 0.74
ROCE % 3.32
Total Debt to Total Equity 0.34
EBITDA Margin 12.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.23
ROE % 0.37
ROCE % 3.30
Total Debt to Total Equity 0.30
EBITDA Margin 11.81
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 8.97
Total Liabilities 8.97
Total Equity 7.13
Share Outstanding 4836500
Price to Book Ratio 0.76
Return on Assets (%) 0.88
Return on Capital (%) 0.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 8.64
Total Liabilities 8.64
Total Equity 7.05
Share Outstanding 4836500
Price to Book Ratio 0.00
Return on Assets (%) 0.53
Return on Capital (%) 0.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 7.98
Total Liabilities 7.98
Total Equity 5.45
Share Outstanding 4061500
Price to Book Ratio 0.00
Return on Assets (%) 0.49
Return on Capital (%) 0.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 7.99
Total Liabilities 7.99
Total Equity 5.41
Share Outstanding 4061500
Price to Book Ratio 0.77
Return on Assets (%) 0.47
Return on Capital (%) 0.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.66
Total Liabilities 7.66
Total Equity 5.37
Share Outstanding 4061500
Price to Book Ratio 0.00
Return on Assets (%) 0.26
Return on Capital (%) 0.29
Particulars MAR 2025 (Values in Cr)
Net Income 0.09
Cash from Operations -0.56
Cash from Investing 1.18
Cash from Financing -0.33
Net change in Cash 0.27
Free Cash Flow -0.46
Particulars MAR 2024 (Values in Cr)
Net Income 0.06
Cash from Operations -1.24
Cash from Investing 0.12
Cash from Financing 1.13
Net change in Cash 0.00
Free Cash Flow -1.22
Particulars MAR 2023 (Values in Cr)
Net Income 0.05
Cash from Operations -0.02
Cash from Investing 0.49
Cash from Financing -0.44
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 0.05
Cash from Operations -0.19
Cash from Investing 0.18
Cash from Financing 0.02
Net change in Cash 0.00
Free Cash Flow -0.18
Particulars MAR 2021 (Values in Cr)
Net Income 0.03
Cash from Operations -0.16
Cash from Investing 0.27
Cash from Financing -0.09
Net change in Cash 0.00
Free Cash Flow -0.14
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 12.86 1.72 241.47 30.00 / 68.00
BLISS GVS PHARMA LTD 152.50 15.10 1.53 1609.97 105.05 / 190.65
CIPLA LTD 1573.80 23.57 4.07 127124.34 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 363.70 10.24 2.95 1070.41 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2774.95 49.64 24.09 47009.33 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 17.13 4.97 241.47 30.00 / 68.00
AMRUTAJAN HEALTH LTD 755.35 40.05 6.68 2183.76 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9004.20 106.45 29.22 22510.50 6222.35 / 10653.05
BLISS GVS PHARMA LTD 152.50 22.80 1.52 1609.97 105.05 / 190.65

Ganga Pharmaceuticals Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
14.60 0.00 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
14.60 PIVOT

First Support

14.60

First Resistance

14.60

Second Support

14.60

Second Resistance

14.60

Third Support

14.60

Third Resistance

14.60

RSI

45.99

ADX

56.35

MACD

0.00

Williams % R

-3.60

Commodity Channel Index (CCI)

28.42

Date

2025-09-03

Week

8000.00

Same Day

8000.00

Month

8000.00

1 Year

4.09

3 Year

1.94

Over 1 Month

0.00%

down

Over 1 Year

-25.39%

down

Over 3 Months

0.00%

down

Over 3 Years

14.40%

down

Over 6 Months

32.72%

down

Over 5 Years

6.21%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Ganga Pharmaceuticals Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
49.08%
Promoter Holdings
50.91%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sharma Bharat B 1456585.0 (24.64%) Shareholding of Promoter and Promoter Group
Srijna Sharma 441905.0 (7.48%) Shareholding of Promoter and Promoter Group
Bhavesh Dhirajlal Tanna 391000.0 (6.61%) Public Shareholding
Plutus Capital Management Llp 375000.0 (6.34%) Public Shareholding
Lenus Finvest Private Limited 375000.0 (6.34%) Public Shareholding
Anagh Bharat Sharma 360000.0 (6.09%) Shareholding of Promoter and Promoter Group
Brijmohan Sharma Huf 349500.0 (5.91%) Shareholding of Promoter and Promoter Group
Prakash Dhirajlal Tanna 325000.0 (5.5%) Public Shareholding
Bharat Brijmohan Sharma Huf Sharma 190000.0 (3.21%) Shareholding of Promoter and Promoter Group
Mr. Niranjan Kumar Goel 144000.0 (2.44%) Public Shareholding
Usha Shukla 95110.0 (1.61%) Shareholding of Promoter and Promoter Group
Amit Shukla 76450.0 (1.29%) Shareholding of Promoter and Promoter Group
Akshay Amarnath Sharma 72000.0 (1.22%) Public Shareholding
Sanjay Dhansukhlal Shah 72000.0 (1.22%) Public Shareholding
Ankita Amit Shukla 40000.0 (0.68%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Ganga Pharmaceuticals Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Ganga Pharmaceuticals Limited Share Price

Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda).

In Apr.'95, the company took over Ganga pharmaceuticals, a proprietory concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades.

The company which manufactures ayurvedic medicines, started commercial production in Apr.'95. In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra.

The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Ganga Pharmaceuticals Ltd?

Answer Field

Ganga Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 14.60 as on Sep 03 2025 12:00 AM.

What is the Market Cap of Ganga Pharmaceuticals Ltd Share?

Answer Field

The market cap of Ganga Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 7.10 as on Sep 03 2025 12:00 AM.

What is the 52 Week High and Low of Ganga Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Ganga Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 19.57 and ₹ 9.25.

What is 1 year return for Ganga Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -25.39%.

What is the P/E Ratio of Ganga Pharmaceuticals Ltd Share?

Answer Field

As on Sep 03 2025 12:00 AM the price-to-earnings (PE) ratio for Ganga Pharmaceuticals Ltd share is 91.25.

What is the PB ratio of Ganga Pharmaceuticals Ltd Share?

Answer Field

As on Sep 03 2025 12:00 AM, the price-to-book (PB) ratio for Ganga Pharmaceuticals Ltd share is 13.46.

How to Buy Ganga Pharmaceuticals Ltd Share?

Answer Field

You can trade in Ganga Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ganga Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Ganga Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ganga Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91